DOXORUBICIN

Clinical trials for DOXORUBICIN explained in plain language.

Never miss a new study

Get alerted when new DOXORUBICIN trials appear

Sign up with your email to follow new studies for DOXORUBICIN, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.

Our safety recommendation!

By submitting, you agree to our Terms of use

Trials to join now! 1 Not yet recruiting 1 Completed 1

New drug combo shows promise for aggressive bladder cancer

Disease control Recruiting now

This study tests whether adding the immunotherapy drug durvalumab to standard chemotherapy before bladder removal surgery is safe and effective for people with muscle-invasive bladder cancer. About 150 participants will receive the drug combination, then undergo surgery. The goal…

Matched conditions: DOXORUBICIN

Phase: PHASE3 • Sponsor: AstraZeneca • Aim: Disease control

Last updated May 15, 2026 11:54 UTC

DOXORUBICIN

Get alerted when new DOXORUBICIN trials appear

New drug combo shows promise for aggressive bladder cancer